Medical Records and Statistics Room, People's Hospital of Chongqing Banan District, Chongqing, China.
Department of Cardiology, People's Hospital of Chongqing Banan District, Chongqing, China.
Front Public Health. 2022 Mar 8;10:780704. doi: 10.3389/fpubh.2022.780704. eCollection 2022.
Liver cirrhosis is a major global health and economic challenge, placing a heavy economic burden on patients, families, and society. This study aimed to investigate medical expenditure trends in patients with liver cirrhosis and assess the drivers for such medical expenditure among patients with liver cirrhosis.
Medical expenditure data concerning patients with liver cirrhosis was collected in six tertiary hospitals in Chongqing, China, from 2012 to 2020. Trends in medical expenses over time and trends according to subgroups were described, and medical expenditure compositions were analyzed. A multiple linear regression model was constructed to evaluate the factors influencing medical expenditure. All expenditure data were reported in Chinese Yuan (CNY), based on the 2020 value, and adjusted using the year-specific health care consumer price index for Chongqing.
Medical expenditure for 7,095 patients was assessed. The average medical expenditure per patient was 16,177 CNY. An upward trend in medical expenditure was observed in almost all patient subgroups. Drug expenses were the largest contributor to medical expenditure in 2020. A multiple linear regression model showed that insurance type, sex, age at diagnosis, marital status, length of stay, smoking status, drinking status, number of complications, autoimmune liver disease, and the age-adjusted Charlson comorbidity index score were significantly related to medical expenditure.
Conservative estimates suggest that the medical expenditure of patients with liver cirrhosis increased significantly from 2012 to 2020. Therefore, it is necessary to formulate targeted measures to reduce the personal burden on patients with liver cirrhosis.
肝硬化是全球面临的重大健康和经济挑战，给患者、家庭和社会带来了沉重的经济负担。本研究旨在调查肝硬化患者的医疗支出趋势，并评估肝硬化患者医疗支出的驱动因素。
本研究在中国重庆市的 6 家三级医院收集了 2012 年至 2020 年期间肝硬化患者的医疗支出数据。描述了随时间变化的医疗支出趋势和亚组趋势，并分析了医疗支出构成。构建了多元线性回归模型来评估影响医疗支出的因素。所有支出数据均以人民币（CNY）报告，并根据 2020 年的价值进行了调整，采用重庆市特定年份的医疗保健消费者价格指数进行了调整。
评估了 7095 例患者的医疗支出。每位患者的平均医疗支出为 16177 元。几乎所有患者亚组的医疗支出都呈上升趋势。2020 年，药物支出是医疗支出的最大贡献者。多元线性回归模型显示，保险类型、性别、诊断时的年龄、婚姻状况、住院时间、吸烟状况、饮酒状况、并发症数量、自身免疫性肝病以及年龄调整后的 Charlson 合并症指数评分与医疗支出显著相关。
保守估计表明，2012 年至 2020 年，肝硬化患者的医疗支出显著增加。因此，有必要制定有针对性的措施来减轻肝硬化患者的个人负担。
